7Baggers
The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.

Evolus, Inc
(NASDAQ:EOLS) 

EOLS stock logo

Evolus, Inc., a performance beauty company, provides products in the self-pay aesthetic healthcare market for physicians and their patients in the United States. The company offers products for physicians that are sold to consumers or used in procedures for aesthetic indications, which are not reimb...

Founded: 2012
Full Time Employees: 125
Sector: Healthcare
Industry: Drug Manufacturers-Specialty & Generic

Share this website to your friends
Evolus Number of Twitter Followers
202204 202206 202207 202208 202209 202210 202211 202212 202301 202302 202303 202304 202305 202306 202307 202308 202309 202310 090.14180.29270.43360.57450.71540.86631
Evolus Days Payable Outstanding ttm (DPO)
202209 202210 202211 202212 202301 202302 202303 202304 202305 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 202404 036.0472.09108.13144.17180.21216.26252.3
Evolus Days Receivable Outstanding ttm (DSO)
202209 202210 202211 202212 202301 202302 202303 202304 202305 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 202404 08.9717.9326.935.8744.8353.862.77
Evolus Days Inventory Outstanding ttm (DIO)
202209 202210 202211 202212 202301 202302 202303 202304 202305 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 202404 022.2744.5466.8289.09111.36133.63155.91
Evolus Op Cashflow Per Share ttm
202209 202210 202211 202212 202301 202302 202303 202304 202305 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 202404 -618.76-530.37-441.97-353.58-265.18-176.79-88.390
Evolus Free Cashflow Per Share ttm
202209 202210 202211 202212 202301 202302 202303 202304 202305 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 202404 -620-531.43-442.86-354.29-265.72-177.14-88.570
Evolus Cash Per Share ttm
202209 202210 202211 202212 202301 202302 202303 202304 202305 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 202404 00.220.430.650.861.081.291.51
Evolus P/S ratio ttm
202209 202210 202211 202212 202301 202302 202303 202304 202305 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 202404 00.661.321.982.653.313.974.63
Evolus (GAAP) P/E ratio ttm
202209 202210 202211 202212 202301 202302 202303 202304 202305 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 202404 -13.49-11.56-9.64-7.71-5.78-3.85-1.930
Evolus P/B ratio ttm
202209 202210 202211 202212 202301 202302 202303 202304 202305 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 202404 -81.01-59.14-37.27-15.46.4728.3550.2272.09
No extra charts and metrics for this ticker.